Physician profile
Hennah Hashmi
NPI 1073824710
$980.14
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2020: $104.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $164.82 | 2019-2020 | |
| Novo Nordisk INC | $127.75 | 2019 | |
| Amgen INC. | $113.41 | 2019-2020 | |
| Amarin Pharma, INC. | $103.25 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $75.01 | 2019 | |
| Astellas Pharma US INC | $68.70 | 2019 | |
| Pfizer INC. | $64.07 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $59.23 | 2019 | |
| Glaxosmithkline, LLC. | $39.74 | 2019 | |
| Sanofi Pasteur INC. | $27.31 | 2019 | |
| Merck Sharp & Dohme LLC | $26.89 | 2019 | |
| Ironshore Pharmaceuticals INC. | $26.70 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.54 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $20.98 | 2019 | |
| Genentech USA, INC. | $15.52 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12.25 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $10.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hennah Hashmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.